Psychotic Disorders: all 1,655 studies
Page 17 of 17. Open to participants first (298), then studies with results posted, then the rest; newest registration first within each.
- A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of AdolescentsCompletedNCT00163865
- Functional Brain Activation Patterns in Schizophrenia, Measured Before and After TreatmentCompletedNCT00161057
- Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeTerminatedNCT00160147Phase 3
- Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic PatientsCompletedNCT00159770Phase 3
- Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode PsychosisStatus unknownNCT00157313Not applicable
- A Study of Strategies to Improve Schizophrenia TreatmentCompletedNCT00156637Not applicable
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in SchizophreniaCompletedNCT00148083Phase 3
- An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00146523Phase 3
- Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind StudyCompletedNCT00145444Phase 3
- To Evaluate the Impact of Treatment Interruption on Re-initiation of BifeprunoxCompletedNCT00141479Phase 2
- Valnoctamide in ManiaCompletedNCT00140179Phase 3
- Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderCompletedNCT00139919Phase 2
- Twice Daily Titration Study of Bifeprunox in Subjects With SchizophreniaCompletedNCT00139906Phase 2
- Israel Multicenter D-Serine Study (IMSER) for the Treatment of SchizophreniaStatus unknownNCT00138775Phase 2
- Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective DisorderCompletedNCT00137020Phase 4
- Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2CompletedNCT00135772
- A United States Study of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00130676Phase 3
- An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128505Phase 3
- A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128479Phase 3
- Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)CompletedNCT00119574Not applicable
- The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
- Generalization of Training in SchizophreniaCompletedNCT00108199Not applicable
- Psychiatric Advance Directives for Improved Mental Health CareCompletedNCT00105794Not applicable
- Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00100776Phase 4
- Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseCompletedNCT00095810Phase 4
- Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderCompletedNCT00095524Phase 3
- Pharmacokinetic Characterization of Intramuscular Olanzapine DepotCompletedNCT00094640Phase 1
- Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00090012Phase 4
- Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational DrugCompletedNCT00087542Phase 2
- Medication Adherence in Older People With PsychosisStatus unknownNCT00071604Not applicable
- Brain Cell Injury in Patients With A First Episode of PsychosisCompletedNCT00070889
- Enhancing the Outcome of Skills Training for People With SchizophreniaCompletedNCT00069433Not applicable
- Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective DisorderCompletedNCT00061802Phase 4
- Effects of Modafinil on Brain Function in Patients With SchizophreniaCompletedNCT00057707Phase 1
- Improving Antipsychotic Adherence Among Patients With Serious Mental IllnessCompletedNCT00057135Not applicable
- Treatment of Schizophrenia Through Internet-Based PsychoeducationCompletedNCT00051233Phase 2
- Screening for Childhood-Onset Psychotic DisordersTerminatedNCT00049738
- Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1TerminatedNCT00046813Phase 4
- The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderCompletedNCT00044187Phase 4
- Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)CompletedNCT00043849Phase 4
- Broad Effectiveness: Study With AripiprazoleCompletedNCT00036361Phase 3
- A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00035802Phase 3
- CAFE Comparison of Atypicals in First Episode of PsychosisCompletedNCT00034892Phase 3
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCompletedNCT00034801Phase 4
- A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.CompletedNCT00034775Phase 3
- Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00018642Not applicable
- Cognitive - Behavioral TherapyCompletedNCT00018629Phase 2
- Treatment of Behavioral Symptoms in Alzheimer's DiseaseCompletedNCT00009217Phase 4
- To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaCompletedNCT00007774Phase 4
- Glycine to Treat Psychotic Disorders in ChildrenCompletedNCT00005658Phase 2
- Genetic Study of SchizophreniaCompletedNCT00001486
- New Drugs in the Treatment of Mood DisordersCompletedNCT00001482Phase 2
- Studies of Frontal Lobe Brain Functioning in SchizophreniaCompletedNCT00001258
- Inpatient Evaluation of Adults With SchizophreniaCompletedNCT00001247
- Evaluating Genetic Risk Factors for Childhood-Onset SchizophreniaTerminatedNCT00001198